WHO study: MDR-TB infection rate reaches highest ever level

3 March 2008

The occurrence of multi-drug resistant tuberculosis has reached its highest ever level, according to a new report from the World Health Organization. The study, entitled Anti-Tuberculosis Drug Resistance in the World, is based on information collected between 2002 and 2006 from 90,000 TB patients in 81 countries around the world.

The report provides further evidence of the diseases' link to HIV with, for example, the recorded incidence of MDR-TB infection in Latvia and the Ukraine among HIV patients being around double that seen in the HIV-negative TB-infected population. In addition, the survey reveals that cases of extensively drug-resistant tuberculosis (XDR-TB), a virtually untreatable form of the disease, have been recorded in as many as 45 of the countries that participated.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight